WA
AGN

WestEnd Advisors’s Allergan Inc AGN Stock Holding History

WestEnd Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-120
Closed -$10.1K – 51
2013
Q2 		$10.1K Buy
+120
New +$12.4K ﹤0.01% 37

Other funds holding AGN

LTI
Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WestEnd Advisors's AGN Position: Q3 2013 in Review

WestEnd Advisors sold out of Allergan Inc (AGN) in Q3 2013, closing a stake of 120 shares — an estimated $10.1K sold.

WestEnd Advisors first reported a position in AGN in Q2 2013 and held it in 1 quarter. The position peaked at $10.1K in Q2 2013. 642 funds tracked by Wall St. Rank hold AGN as of Q3 2013.

  • WestEnd Advisors reported no remaining Allergan Inc position as of Q3 2013 after selling out during the quarter.
  • WestEnd Advisors sold 120 Allergan Inc shares in Q3 2013, an estimated $10.1K.
  • WestEnd Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 1 quarter.
  • WestEnd Advisors's Allergan Inc position peaked at $10.1K in Q2 2013.
  • 642 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2013.

Based on WestEnd Advisors's 13F filing for Q3 2013, filed 28 Oct 2013.